UBS lists 4 reasons why it may be a good time to look at infrastructure now

UBS lists 4 reasons why it may be a good time to look at infrastructure now

UBS lists 4 reasons why it may be a good time to look at infrastructure now
Global Banking & Finance Review® is an online platform providing news, analysis, interviews, opinions, press releases, market information and other content relating to banking, finance, insurance, investment, wealth management, fintech, financial markets, technology, regulation and related industries worldwide. The website publishes editorial content, news, press releases, contributed articles, sponsored content, advertorials, advertisements and other material…
Newmark arranged the $130-million sale of the 222,073-square-foot NorthBay Health Medical Outpatient Building Collection, compromised of six fully leased healthcare assets across Fairfield and Vacaville. Co-heads of U.S. Medical Office Capital Markets Ben Appel, Justin Shepherd and Jay Miele, head of healthcare debt John Nero, senior managing director Michael Greeley and associate director Ron Ott…
Follow ATOSS Software SE (ATSWF) Q3 2026 Earnings Call October 23, 2026 3:30 AM EDT Company Participants Carla Leicher – Manager of Corporate DevelopmentChristof Leiber – CFO & Member of Management Board Conference Call Participants Jarrod Chisholm – UBS Investment Bank, Research DivisionGustav Froberg – Joh. Berenberg, Gossler & Co. KG, Research DivisionNicolas Herms –…
The share of adults struggling to afford their rent or mortgage payments has fallen significantly from the highs seen during the cost-of-living crisis, according to Office for National Statistics (ONS) data. Some 30% of adults who pay rent or mortgage bills said they found these payments very or somewhat difficult to afford. This is…
Global Banking & Finance Review® is an online platform providing news, analysis, interviews, opinions, press releases, market information and other content relating to banking, finance, insurance, investment, wealth management, fintech, financial markets, technology, regulation and related industries worldwide. The website publishes editorial content, news, press releases, contributed articles, sponsored content, advertorials, advertisements and other material…
Data presented at ESMO highlight the promising efficacy of olomorasib in combination with standard-of-care immunotherapy with or without chemotherapy in first-line advanced KRAS G12C-mutant non-small cell lung cancer (NSCLC) across PD-L1 expression levels First-line treatment options remain an unmet need for patients with KRAS G12C-mutant NSCLC, as most patients do not receive second-line therapy due…